000			04025nam a22004095i 4500
001			85069
003			ES-MaUEC
005			20230207040453.0
007			cr nn 008mamaa
008			151224s2016 gw | s |||| 0|eng d
020			_a9783319249933
040			_aES-MaUEC
050		4	_aRC685.C53 _b2016 EB
082	0	4	_a616.12
245	1	0	_aHeart Failure Management: The Neural Pathways _cedited by Edoardo Gronda, Emilio Vanoli, Alexandru Costea
250			_a1st ed.
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (VIII, 216 páginas) _b43 ilustraciones, 18 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPART I CURRENT HEART FAILURE THERAPIES 1 Therapies in heart failure, tomorrow may be too late -- 2 �Atrial fibrillation, heart failure and the autonomic nervous system -- 3 Current therapies for ventricular tachycardia. Are there autonomic implications of the arrhythmogenic substrate? -- PART II THE AUTONOMIC REGULATION AND DIS-REGULATION OF THE HEART: PATHOPHYSIOLOGY IN HEART FAILURE�4 zThe autonomic Nervous system symphony orchestray: Pathophysiology of Autonomic Nervous system and Analysis of Activity Frequences.-�5 Autonomic pathophysiology after myocardial infarction falling into heart failure.-�6 Cardiovascular serenade: listening to the heart.-�7 Whispering during sleep: autonomic signalling during sleep, sleep apnoea and sudden death.-�8 Cerebral aging: Implications for the autonomic nervous system regulation -- PART III MODULATION OF AUTONOMIC FUNCTION IN HEART FAILURE�9 The autonomic cardiorenal cross-talk: pathophysiology and implications for heart failure management.-�10 Vagal Stimulation in Heart failure: an antiinflammatory intervention? -- 11 Baroreflex activation therapy in heart failure -- 12 Renal reflexes and denervation in heart failure -- 13 Conclusions: back to the future.
520	3		_aThis book describes the most recent insights into heart failure and the role played by autonomic nervous system pathophysiology in it, discussing the therapeutic implications. While current therapeutic approaches are able to control the effects of excessive adrenergic activation in heart failure syndrome, the underlying abnormalities of adrenergic control remain unaltered and can still cause progression to unmanageable end-stage heart failure. New therapeutic pathways are therefore being explored with a view to developing interventions that can directly modulate adrenergic over-activity and restore a more appropriate balance in neural control of the cardiovascular system. The book opens by examining current heart failure therapies. Advances in our understanding of autonomic regulation/dysregulation in heart failure are then discussed in detail, in the context of the search for more effective therapies. A concluding section addresses the role of autonomic nervous system denervation in heart failure. The authors are top scientists from leading research centers.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aAngiología _0comprobar BNE19923469484 _2embne _9146287
700	1		_aGronda, Edoardo _eeditor literario _0Local _997749
700	1		_aVanoli, Emilio. _eeditor literario _997750 _0Local
700	1		_aCostea, Alexandru _eeditor literario _0Local _997751
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-24993-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319249933
907			_a.b12943472 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC685.C53 H437 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11587672 _z06-04-17
999			_c85069 _d85069 _x1